 | • レポートコード：QYR9ST00517 • 出版社/出版日：QYResearch / 2019年9月2日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、113ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医薬品・医療 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| ※本調査レポートでは、世界の泌尿生殖器薬市場について調査・分析し、以下の構成でお届け致します。泌尿生殖器薬の種類別には、泌尿器科、ホルモン療法、婦人科、抗感染薬に、用途別には、前立腺癌、卵巣癌、膀胱癌、子宮頸癌、腎癌、勃起不全、尿路感染症、尿失禁及び過活動膀胱、性感染症、間質性膀胱炎に、地域別には、北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカなどに区分してセグメント分析を行いました。 ・調査販売 ・エグゼクティブ・サマリー ・企業別泌尿生殖器薬売上データ ・地域別泌尿生殖器薬市場規模：北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカ、その他 ・種類別泌尿生殖器薬市場規模：泌尿器科、ホルモン療法、婦人科、抗感染薬 ・用途別泌尿生殖器薬市場規模：前立腺癌、卵巣癌、膀胱癌、子宮頸癌、腎癌、勃起不全、尿路感染症、尿失禁及び過活動膀胱、性感染症、間質性膀胱炎 ・主要メーカーの企業情報：Novartis AG、Genentech ・泌尿生殖器薬の市場規模予測 ・バリューチェーン及び販売チャネル分析 ・市場機会・課題・リスク・影響因子分析 ... |
A medical science concerned with the study and treatment of diseases of the genital and urinary organs, especially sexually transmitted diseases.The growing prevalence of genitourinary disorders is presumed to be the high rendering impact driver of this vertical. In addition, increasing number of pipeline drugs are expected to widen the scope for growth in the future.
The global Genitourinary Drugs market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Genitourinary Drugs market based on company, product type, end user and key regions.
This report studies the global market size of Genitourinary Drugs in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Genitourinary Drugs in these regions.
This research report categorizes the global Genitourinary Drugs market by top players/brands, region, type and end user. This report also studies the global Genitourinary Drugs market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Novartis AG
Genentech
Market size by Product
Urologicals
Hormonal Therapy
Gynecological
Anti-infectives
Market size by End User
Prostate Cancer
Ovarian Cancer
Bladder Cancer
Cervical Cancer
Renal Cancer
Erectile Dysfunction
Urinary Tract Infections
Urinary Incontinence & Overactive Bladder
Sexually Transmitted Diseases
Interstitial Cystitis
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Genitourinary Drugs market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Genitourinary Drugs market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Genitourinary Drugs companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Genitourinary Drugs submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Genitourinary Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Genitourinary Drugs market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
レポート目次Table of Contents
1 Study Coverage
1.1 Genitourinary Drugs Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Genitourinary Drugs Market Size Growth Rate by Product
1.4.2 Urologicals
1.4.3 Hormonal Therapy
1.4.4 Gynecological
1.4.5 Anti-infectives
1.5 Market by End User
1.5.1 Global Genitourinary Drugs Market Size Growth Rate by End User
1.5.2 Prostate Cancer
1.5.3 Ovarian Cancer
1.5.4 Bladder Cancer
1.5.5 Cervical Cancer
1.5.6 Renal Cancer
1.5.7 Erectile Dysfunction
1.5.8 Urinary Tract Infections
1.5.9 Urinary Incontinence & Overactive Bladder
1.5.10 Sexually Transmitted Diseases
1.5.11 Interstitial Cystitis
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Genitourinary Drugs Market Size
2.1.1 Global Genitourinary Drugs Revenue 2014-2025
2.1.2 Global Genitourinary Drugs Sales 2014-2025
2.2 Genitourinary Drugs Growth Rate by Regions
2.2.1 Global Genitourinary Drugs Sales by Regions
2.2.2 Global Genitourinary Drugs Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Genitourinary Drugs Sales by Manufacturers
3.1.1 Genitourinary Drugs Sales by Manufacturers
3.1.2 Genitourinary Drugs Sales Market Share by Manufacturers
3.1.3 Global Genitourinary Drugs Market Concentration Ratio (CR5 and HHI)
3.2 Genitourinary Drugs Revenue by Manufacturers
3.2.1 Genitourinary Drugs Revenue by Manufacturers (2014-2019)
3.2.2 Genitourinary Drugs Revenue Share by Manufacturers (2014-2019)
3.3 Genitourinary Drugs Price by Manufacturers
3.4 Genitourinary Drugs Manufacturing Base Distribution, Product Types
3.4.1 Genitourinary Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Genitourinary Drugs Product Type
3.4.3 Date of International Manufacturers Enter into Genitourinary Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Genitourinary Drugs Sales by Product
4.2 Global Genitourinary Drugs Revenue by Product
4.3 Genitourinary Drugs Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Genitourinary Drugs Breakdown Data by End User
6 North America
6.1 North America Genitourinary Drugs by Countries
6.1.1 North America Genitourinary Drugs Sales by Countries
6.1.2 North America Genitourinary Drugs Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Genitourinary Drugs by Product
6.3 North America Genitourinary Drugs by End User
7 Europe
7.1 Europe Genitourinary Drugs by Countries
7.1.1 Europe Genitourinary Drugs Sales by Countries
7.1.2 Europe Genitourinary Drugs Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Genitourinary Drugs by Product
7.3 Europe Genitourinary Drugs by End User
8 Asia Pacific
8.1 Asia Pacific Genitourinary Drugs by Countries
8.1.1 Asia Pacific Genitourinary Drugs Sales by Countries
8.1.2 Asia Pacific Genitourinary Drugs Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Genitourinary Drugs by Product
8.3 Asia Pacific Genitourinary Drugs by End User
9 Central & South America
9.1 Central & South America Genitourinary Drugs by Countries
9.1.1 Central & South America Genitourinary Drugs Sales by Countries
9.1.2 Central & South America Genitourinary Drugs Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Genitourinary Drugs by Product
9.3 Central & South America Genitourinary Drugs by End User
10 Middle East and Africa
10.1 Middle East and Africa Genitourinary Drugs by Countries
10.1.1 Middle East and Africa Genitourinary Drugs Sales by Countries
10.1.2 Middle East and Africa Genitourinary Drugs Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Genitourinary Drugs by Product
10.3 Middle East and Africa Genitourinary Drugs by End User
11 Company Profiles
11.1 Novartis AG
11.1.1 Novartis AG Company Details
11.1.2 Company Business Overview
11.1.3 Novartis AG Genitourinary Drugs Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Novartis AG Genitourinary Drugs Products Offered
11.1.5 Novartis AG Recent Development
11.2 Genentech
11.2.1 Genentech Company Details
11.2.2 Company Business Overview
11.2.3 Genentech Genitourinary Drugs Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Genentech Genitourinary Drugs Products Offered
11.2.5 Genentech Recent Development
12 Future Forecast
12.1 Genitourinary Drugs Market Forecast by Regions
12.1.1 Global Genitourinary Drugs Sales Forecast by Regions 2019-2025
12.1.2 Global Genitourinary Drugs Revenue Forecast by Regions 2019-2025
12.2 Genitourinary Drugs Market Forecast by Product
12.2.1 Global Genitourinary Drugs Sales Forecast by Product 2019-2025
12.2.2 Global Genitourinary Drugs Revenue Forecast by Product 2019-2025
12.3 Genitourinary Drugs Market Forecast by End User
12.4 North America Genitourinary Drugs Forecast
12.5 Europe Genitourinary Drugs Forecast
12.6 Asia Pacific Genitourinary Drugs Forecast
12.7 Central & South America Genitourinary Drugs Forecast
12.8 Middle East and Africa Genitourinary Drugs Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Genitourinary Drugs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Figure Genitourinary Drugs Product Picture
Table Genitourinary Drugs Market Segments
Table Key Manufacturers Genitourinary Drugs Covered
Table Global Genitourinary Drugs Market Size Growth Rate by Product 2019-2025 (K Units) & (Million US$)
Figure Global Genitourinary Drugs Sales Market Share by Product 2014-2025
Figure Urologicals Product Picture
Table Major Manufacturers of Urologicals
Figure Hormonal Therapy Product Picture
Table Major Manufacturers of Hormonal Therapy
Figure Gynecological Product Picture
Table Major Manufacturers of Gynecological
Figure Anti-infectives Product Picture
Table Major Manufacturers of Anti-infectives
Table Global Genitourinary Drugs Market Size Growth Rate by End User 2019-2025 (K Units)
Figure Prostate Cancer
Figure Ovarian Cancer
Figure Bladder Cancer
Figure Cervical Cancer
Figure Renal Cancer
Figure Erectile Dysfunction
Figure Urinary Tract Infections
Figure Urinary Incontinence & Overactive Bladder
Figure Sexually Transmitted Diseases
Figure Interstitial Cystitis
Figure Genitourinary Drugs Report Years Considered
Figure Global Genitourinary Drugs Market Size 2014-2025 (Million US$)
Figure Global Genitourinary Drugs Sales 2014-2025 (K Units)
Table Global Genitourinary Drugs Market Size by Regions 2014-2019 (K Units) & (Million US$)
Table Global Genitourinary Drugs Sales by Regions 2014-2019 (K Units)
Table Global Genitourinary Drugs Sales Market Share by Regions 2014-2019
Figure Global Genitourinary Drugs Sales Market Share by Regions 2014-2019
Figure 2018 Global Genitourinary Drugs Sales Market Share by Regions
Table Global Genitourinary Drugs Revenue by Regions 2014-2019 (Million US$)
Table Global Genitourinary Drugs Revenue Market Share by Regions 2014-2019
Figure Global Genitourinary Drugs Revenue Market Share by Regions 2014-2019
Figure 2018 Global Genitourinary Drugs Revenue Market Share by Regions
Table Global Genitourinary Drugs Sales by Manufacturers (2014-2019) (K Units)
Table Global Genitourinary Drugs Sales Share by Manufacturers (2014-2019)
Figure Global Genitourinary Drugs Sales Share by Manufacturers in 2018
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Genitourinary Drugs Revenue by Manufacturers (2014-2019) (Million USD)
Table Genitourinary Drugs Revenue Share by Manufacturers (2014-2019)
Figure Genitourinary Drugs Value Share by Manufacturers in 2018
Table Key Manufacturers Genitourinary Drugs Price (2014-2019) (USD/Unit)
Table Genitourinary Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Genitourinary Drugs Product Type
Table Date of International Manufacturers Enter into Genitourinary Drugs Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Genitourinary Drugs Sales by Product (2014-2019) (K Units)
Table Global Genitourinary Drugs Sales Share by Product (2014-2019)
Figure Global Genitourinary Drugs Sales Market Share by Product (2014-2019)
Figure Global Genitourinary Drugs Sales Market Share by Product in 2018
Table Global Genitourinary Drugs Revenue by Product (2014-2019) (Million US$)
Table Global Genitourinary Drugs Revenue Share by Product (2014-2019)
Figure Global Genitourinary Drugs Revenue Market Share by Product (2014-2019)
Figure Global Genitourinary Drugs Revenue Market Share by Product in 2018
Table Genitourinary Drugs Price by Product 2014-2019 (USD/Unit)
Table Global Genitourinary Drugs Sales by End User (2014-2019) (K Units)
Table Global Genitourinary Drugs Sales Share by End User (2014-2019)
Figure Global Sales Genitourinary Drugs Market Share by End User (2014-2019)
Figure Global Sales Genitourinary Drugs Market Share by End User in 2018
Figure North America Genitourinary Drugs Sales Growth Rate 2014-2019 (K Units)
Figure North America Genitourinary Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table North America Genitourinary Drugs Sales by Countries (2014-2019) (K Units)
Table North America Genitourinary Drugs Sales Market Share by Countries (2014-2019)
Figure 2018 North America Genitourinary Drugs Sales Market Share by Countries
Table North America Genitourinary Drugs Revenue by Countries (2014-2019) (Million US$)
Table North America Genitourinary Drugs Revenue Market Share by Countries (2014-2019)
Figure 2018 North America Genitourinary Drugs Revenue Market Share by Countries
Figure United States Genitourinary Drugs Sales Growth Rate (2014-2019) (K Units)
Figure United States Genitourinary Drugs Revenue Growth Rate (2014-2019) (K Units)
Figure Canada Genitourinary Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Canada Genitourinary Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Mexico Genitourinary Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Mexico Genitourinary Drugs Revenue Growth Rate (2014-2019) (Million US$)
Table North America Genitourinary Drugs Sales by Product (2014-2019) (K Units)
Table North America Genitourinary Drugs Sales Market Share by Product (2014-2019)
Figure 2018 North America Genitourinary Drugs Market Share by Product
Table North America Genitourinary Drugs Sales by End User (2014-2019) (K Units)
Table North America Genitourinary Drugs Sales Market Share by End User (2014-2019)
Figure 2018 North America Genitourinary Drugs Market Share by End User
Figure Europe Genitourinary Drugs Sales Growth Rate 2014-2019 (K Units)
Figure Europe Genitourinary Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table Europe Genitourinary Drugs Sales by Countries (2014-2019) (K Units)
Table Europe Genitourinary Drugs Sales Market Share by Countries (2014-2019)
Figure 2018 Europe Genitourinary Drugs Sales Market Share by Countries
Table Europe Genitourinary Drugs Revenue by Countries (2014-2019) (Million US$)
Table Europe Genitourinary Drugs Revenue Market Share by Countries (2014-2019)
Figure 2018 Europe Genitourinary Drugs Revenue Market Share by Countries
Figure Germany Genitourinary Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Germany Genitourinary Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure France Genitourinary Drugs Sales Growth Rate (2014-2019) (K Units)
Figure France Genitourinary Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure UK Genitourinary Drugs Sales Growth Rate (2014-2019) (K Units)
Figure UK Genitourinary Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Italy Genitourinary Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Italy Genitourinary Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Russia Genitourinary Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Russia Genitourinary Drugs Revenue Growth Rate (2014-2019) (Million US$)
Table Europe Genitourinary Drugs Sales by Product (2014-2019) (K Units)
Table Europe Genitourinary Drugs Sales Market Share by Product (2014-2019)
Figure 2018 Europe Genitourinary Drugs Market Share by Product
Table Europe Genitourinary Drugs Sales by End User (2014-2019) (K Units)
Table Europe Genitourinary Drugs Sales Market Share by End User (2014-2019)
Figure 2018 Europe Genitourinary Drugs Market Share by End User
Figure Asia Pacific Genitourinary Drugs Sales Growth Rate 2014-2019 (K Units)
Figure Asia Pacific Genitourinary Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific Genitourinary Drugs Sales by Countries (2014-2019) (K Units)
Table Asia Pacific Genitourinary Drugs Sales Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Genitourinary Drugs Sales Market Share by Countries
Table Asia Pacific Genitourinary Drugs Revenue by Countries (2014-2019) (Million US$)
Table Asia Pacific Genitourinary Drugs Revenue Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Genitourinary Drugs Revenue Market Share by Countries
Figure China Genitourinary Drugs Sales Growth Rate (2014-2019) (K Units)
Figure China Genitourinary Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan Genitourinary Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Japan Genitourinary Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea Genitourinary Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Korea Genitourinary Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure India Genitourinary Drugs Sales Growth Rate (2014-2019) (K Units)
Figure India Genitourinary Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia Genitourinary Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Australia Genitourinary Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia Genitourinary Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Indonesia Genitourinary Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia Genitourinary Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Malaysia Genitourinary Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines Genitourinary Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Philippines Genitourinary Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand Genitourinary Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Thailand Genitourinary Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam Genitourinary Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Vietnam Genitourinary Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Singapore Genitourinary Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Singapore Genitourinary Drugs Revenue Growth Rate (2014-2019) (Million US$)
Table Asia Pacific Genitourinary Drugs Sales by Product (2014-2019) (K Units)
Table Asia Pacific Genitourinary Drugs Sales Market Share by Product (2014-2019)
Figure 2018 Asia Pacific Genitourinary Drugs Market Share by Product
Table Asia Pacific Genitourinary Drugs Sales by End User (2014-2019) (K Units)
Table Asia Pacific Genitourinary Drugs Sales Market Share by End User (2014-2019)
Figure 2018 Asia Pacific Genitourinary Drugs Market Share by End User
Figure Central & South America Genitourinary Drugs Sales Growth Rate 2014-2019 (K Units)
Figure Central & South America Genitourinary Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America Genitourinary Drugs Sales by Countries (2014-2019) (K Units)
Table Central & South America Genitourinary Drugs Sales Market Share by Countries (2014-2019)
Figure 2018 Central & South America Genitourinary Drugs Sales Market Share by Countries
Table Central & South America Genitourinary Drugs Revenue by Countries (2014-2019) (Million US$)
Table Central & South America Genitourinary Drugs Revenue Market Share by Countries (2014-2019)
Figure 2018 Central & South America Genitourinary Drugs Revenue Market Share by Countries
Figure Brazil Genitourinary Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Brazil Genitourinary Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Argentina Genitourinary Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Argentina Genitourinary Drugs Revenue Growth Rate (2014-2019) (Million US$)
Table Central & South America Genitourinary Drugs Sales by Product (2014-2019) (K Units)
Table Central & South America Genitourinary Drugs Sales Market Share by Product (2014-2019)
Figure 2018 Central & South America Genitourinary Drugs Market Share by Product
Table Central & South America Genitourinary Drugs Sales by End User (2014-2019) (K Units)
Table Central & South America Genitourinary Drugs Sales Market Share by End User (2014-2019)
Figure 2018 Central & South America Genitourinary Drugs Market Share by End User
Figure Middle East and Africa Genitourinary Drugs Sales Growth Rate 2014-2019 (K Units)
Figure Middle East and Africa Genitourinary Drugs Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa Genitourinary Drugs Sales by Countries (2014-2019) (K Units)
Table Middle East and Africa Genitourinary Drugs Sales Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Genitourinary Drugs Sales Market Share by Countries
Table Middle East and Africa Genitourinary Drugs Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa Genitourinary Drugs Revenue Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Genitourinary Drugs Revenue Market Share by Countries
Figure GCC Countries Genitourinary Drugs Sales Growth Rate (2014-2019) (K Units)
Figure GCC Countries Genitourinary Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Turkey Genitourinary Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Turkey Genitourinary Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure Egypt Genitourinary Drugs Sales Growth Rate (2014-2019) (K Units)
Figure Egypt Genitourinary Drugs Revenue Growth Rate (2014-2019) (Million US$)
Figure South Africa Genitourinary Drugs Sales Growth Rate (2014-2019) (K Units)
Figure South Africa Genitourinary Drugs Revenue Growth Rate (2014-2019) (Million US$)
Table Middle East and Africa Genitourinary Drugs Sales by Product (2014-2019) (K Units)
Table Middle East and Africa Genitourinary Drugs Sales Market Share by Product (2014-2019)
Figure 2018 Middle East and Africa Genitourinary Drugs Market Share by Product
Table Middle East and Africa Genitourinary Drugs Sales by End User (2014-2019) (K Units)
Table Middle East and Africa Genitourinary Drugs Sales Market Share by End User (2014-2019)
Figure 2018 Middle East and Africa Genitourinary Drugs Market Share by End User
Table Novartis AG Company Details
Table Novartis AG Genitourinary Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Novartis AG Recent Development
Table Genentech Company Details
Table Genentech Genitourinary Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2014-2019)
Table Genentech Recent Development
Table Global Genitourinary Drugs Sales Forecast by Regions 2019-2025 (K Units)
Table Global Genitourinary Drugs Sales Market Share Forecast by Regions 2019-2025
Table Global Genitourinary Drugs Revenue Forecast by Regions 2019-2025 (Million US$)
Table Global Genitourinary Drugs Revenue Market Share Forecast by Regions 2019-2025
Table Global Genitourinary Drugs Sales Forecast by Product 2019-2025 (K Units)
Table Global Genitourinary Drugs Sales Market Share Forecast by Product 2019-2025
Table Global Genitourinary Drugs Revenue Forecast by Product 2019-2025 (Million US$)
Table Global Genitourinary Drugs Revenue Market Share Forecast by Product 2019-2025
Table Global Genitourinary Drugs Sales Forecast by End User 2019-2025 (K Units)
Table Global Genitourinary Drugs Sales Market Share Forecast by End User 2019-2025
Figure North America Genitourinary Drugs Sales Growth Rate Forecast (2019-2025) (K Units)
Figure North America Genitourinary Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Europe Genitourinary Drugs Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Europe Genitourinary Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Asia Pacific Genitourinary Drugs Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Asia Pacific Genitourinary Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Central & South America Genitourinary Drugs Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Central & South America Genitourinary Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Middle East and Africa Genitourinary Drugs Sales Growth Rate Forecast (2019-2025) (K Units)
Figure Middle East and Africa Genitourinary Drugs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Table Genitourinary Drugs Value Chain
Table Genitourinary Drugs Customers List
Table Genitourinary Drugs Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
前立腺癌治療薬の世界市場：市場規模・現状・予測 Adoption of innovative technologies in screening & diagnostic tests is projected to drive growth. The incorporation of multiparametric MRI (mp-MRI) can significantly improve the detection of tumor and also provide confirmation whether there is a need for tissue biopsy. In addition, market players ar…- がん支持療法薬の世界市場：市場規模・現状・予測 Supportive drugs are not anticancer drugs. They protect certain cells or organs from the side effects of chemotherapy drugs or radiation therapy.Increasing uptake of biosimilars, rising expenditure on healthcare, and availability of effective treatment methods, including target specific and tailored…
- 尿路上皮がん薬の世界市場：市場規模・現状・予測 Urothelial carcinoma or transitional cell carcinoma is a malignant neoplasm occurring from urothelium. The disease is the ninth most common malignancy in the world, with approximately 2.5 million patients and 420,000 newly diagnosed cases each year. Bladder transitional cell carcinoma (TCC) accounte…
- 尿路上皮がん薬の世界市場：市場規模・現状・予測 Urothelial carcinoma or transitional cell carcinoma is a malignant neoplasm occurring from urothelium. The disease is the ninth most common malignancy in the world, with approximately 2.5 million patients and 420,000 newly diagnosed cases each year. Bladder transitional cell carcinoma (TCC) accounte…
- 肺癌治療薬の世界市場：市場規模・現状・予測 Lung Cancer Treatment Drugs are durgs used to cure lung cancer.In the coming years, it is expected that the global Lung Cancer Treatment Drugs market will advance with higher growth rate as compared to previous years. Factors such as Smoking, Rising cases of infections, Rising rates of fast growing …